Skip to main content

Irinotecan Hydrochloride Injection Shortage

Last Updated: August 4, 2025
Status: Discontinued

To Be Discontinued:

Injection, 100 mg per 5 mL (20mg per mL) (Fresenius Kabi USA, LLC)

NDC Code: 63323-193-55
Status: To Be Discontinued
Date of update: September 30, 2024
Update type: New
Therapeutic category: Oncology
Date discontinued: September 30, 2024
Initial posting date: September 30, 2024
Contact info: 888-386-1300

Injection, 40 mg per 2 mL (20mg per mL) (Fresenius Kabi USA, LLC)

NDC Code: 63323-193-52
Status: To Be Discontinued
Date of update: September 30, 2024
Update type: New
Therapeutic category: Oncology
Date discontinued: September 30, 2024
Initial posting date: September 30, 2024
Contact info: 888-386-1300

Irinotecan Hydrochloride, Injection, 20 mg/1 mL (Teva Pharmaceuticals USA, Inc.)

NDC Code: 45963-614-51
Status: To Be Discontinued
Date of update: August 4, 2025
Update type: New
Related Information: Product not anticipated to be available beyond mid-late October 2025
Therapeutic category: Oncology
Date discontinued: August 4, 2025
Initial posting date: August 4, 2025
Contact info: 800-545-8800

Irinotecan Hydrochloride, Injection, 20 mg/1 mL (Teva Pharmaceuticals USA, Inc.)

NDC Code: 45963-614-55
Status: To Be Discontinued
Date of update: August 4, 2025
Update type: New
Related Information: Product not anticipated to be available beyond mid-late September 2025
Therapeutic category: Oncology
Date discontinued: August 4, 2025
Initial posting date: August 4, 2025
Contact info: 800-545-8800

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer